Amendment 0001.pdf

This document is an amendment to solicitation HT9402-25-Q-9101 for the Department of Defense (DoD) Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program. The amendment updates the NDC price list quote due date from December 19, 2024 to December 30, 2024, adds an updated RFQ document specific for class reviews without clinical responses, and adds Sodium Oxybate to the drug class list. The solicitation is for the DoD to establish an integrated pharmacy benefits program, including the purchase of pharmaceutical agents. The P&T Committee will review the clinical and cost effectiveness of agents in the Narcotic Analgesics and Combinations, and Sleep Disorders: Wakefulness Promoting Agents drug classes at the February 2025 meeting. The RFQ, including UF BPA and UF ADP appendices, provides instructions, deadlines, and points of contact. A pre-quotation teleconference is scheduled for November 12, 2024, and responses to clinical questions are due by the date stated in Part 2.4.